Table 2.
Mean (± SEM) values of mannan-binding lectin (MBL) level in patients with hypopituitarism (n=42) who are on appropriate replacement therapies (compensated hypopituitarism, n=10) vs. inadequate replacement therapies (non-compensated hypopituitarism, n=32) presented in particular subgroups of individuals depending on how many pituitary axes are involved.
Compensated hypopituitarism (n=10) | Non-compensated hypopituitarism (n=32) | |
---|---|---|
One pituitary deficiency (n=9) | 1662.73 ± 581.48 n=5 |
1494.68 ± 660.73 n=4 |
Two pituitary deficiencies (n=7) | 6562.51 n=1 |
1042.48 ± 509.37 n=6 |
Three pituitary deficiencies (n=9) | 1736.58 ± 456.18 n=2 |
1335.99 ± 773.59 n=7 |
Four pituitary deficiencies (n=12) | 2325.82 ± 1061.62 n=2 |
955.13 ± 439.57 n=10 |
Five pituitary deficiencies (n=5) | - n=0 |
507.02 ± 246.51 n=5 |
Statistical evaluation was performed by Mann-Whitney U test. No statistically significant differences were found.